BaHoF5 nanoprobes as high-performance contrast agents for multi-modal CT imaging of ischemic stroke

Biomaterials

Volumn 71, Issue , 2015, Pages 110-118

  Wang, Jing ^a   Ni, Dalong ^b   Bu, Wenbo ^a,b   Zhou, Qian ^a   Fan, Wenpei ^b   Wu, Yue ^a   Liu, Yanyan ^b   Yin, Lekang ^a   Cui, Zhaowen ^b   Zhang, Xiaoxue ^a   Zhang, Hua ^a   Yao, Zhenwei ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

BaHoF5 nanoparticles; CT angiography imaging; CT perfusion imaging; Ischemic stroke; Multi modal CT imaging

Indexed keywords

ANGIOGRAPHY; BARIUM COMPOUNDS; HOLMIUM COMPOUNDS; NANOPARTICLES; SYNTHESIS (CHEMICAL);

ACUTE ISCHEMIC STROKE; CONTRAST-ENHANCED IMAGING; CT ANGIOGRAPHY; CT IMAGING; CT PERFUSION IMAGING; DIFFERENT VOLTAGES; IMAGING EFFICIENCY; ISCHEMIC STROKES;

COMPUTERIZED TOMOGRAPHY;

BARIUM HOLMIUM PENTAFLUORIDE; CONTRAST MEDIUM; IODINATED CONTRAST MEDIUM; IOHEXOL; MACROGOL; UNCLASSIFIED DRUG; BARIUM DERIVATIVE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG DISTRIBUTION; DRUG SYNTHESIS; MOUSE; NANOPROBE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RAT; SENSITIVITY AND SPECIFICITY; ANIMAL; CELL LINE; CEREBROVASCULAR ACCIDENT; CHEMISTRY; MALE; RADIOGRAPHY; SPRAGUE DAWLEY RAT;

ANIMALS; BARIUM COMPOUNDS; BRAIN ISCHEMIA; CELL LINE; CONTRAST MEDIA; MALE; MICE; NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84941559151     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.08.038     Document Type: Article

References (34)

1. Bushnell C., McCullough L.D., Awad I.A., Chireau M.V., Fedder W.N., Furie K.L., et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American heart association/American stroke association. Stroke 2014, 45:1545-1588.
2. Kelly-Hayes M., Beiser A., Kase C.S., Scaramucci A., D'Agostino R.B., Wolf P.A. The influence of gender and age on disability following ischemic stroke: the framingham study. J. Stroke Cerebrovasc. Dis. 2003, 12:119-126.
3. Kernan W.N., Ovbiagele B., Black H.R., Bravata D.M., Chimowitz M.I., Ezekowitz M.D., et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2014, 45:2160-2236.
4. Nael K., Khan R., Choudhary G., Meshksar A., Villablanca P., Tay J., et al. Six-minute magnetic resonance imaging protocol for evaluation of acute ischemic stroke: pushing the boundaries. Stroke 2014, 45:1985-1991.
5. Nour M., Liebeskind D.S. Imaging of cerebral ischemia: from acute stroke to chronic disorders. Neurol. Clin. 2014, 32:193-209.
6. Biesbroek J.M., Niesten J.M., Dankbaar J.W., Biessels G.J., Velthuis B.K., Reitsma J.B., et al. Diagnostic accuracy of CT perfusion imaging for detecting acute ischemic stroke: a systematic review and meta-analysis. Cerebrovasc. Dis. 2013, 35:493-501.
7. Hopyan J., Ciarallo A., Dowlatshahi D., Howard P., John V., Yeung R., et al. Certainty of stroke diagnosis: incremental benefit with CT perfusion over noncontrast CT and CT angiography. Radiology 2010, 255:142-153.
8. Murphy A., So A., Lee T.-Y., Symons S., Jakubovic R., Zhang L., et al. Low dose CT perfusion in acute ischemic stroke. Neuroradiology 2014, 56:1055-1062.
9. Z-l Li, Li H., Zhang K., W-j Li, Chen X., Wu B., et al. Improvement of image quality and radiation dose of CT perfusion of the brain by means of low-tube voltage (70 KV). Eur. Radiol. 2014, 24:1906-1913.
10. Tao Y.H., Chen G.H., Hacker T.A., Raval A.N., Van Lysel M.S., Speidel M.A. Low dose dynamic CT myocardial perfusion imaging using a statistical iterative reconstruction method. Med. Phys. 2014, 41. 071914(1)-071914(14).
11. Davenport M.S., Khalatbari S., Dillman J.R., Cohan R.H., Caoili E.M., Ellis J.H. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 2013, 267:94-105.
12. Lakhal K., Ehrmann S., Chaari A., Laissy J.P., Regnier B., Wolff M., et al. Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J. Crit. Care 2011, 26:593-599.
13. 3 nanodots as a contrast agent for in vivo X-ray computed tomography imaging. Adv. Mater. 2011, 23:4886-4891.
14. Liu Y., Ai K., Liu J., Yuan Q., He Y., Lu L. Hybrid BaYbF(5) nanoparticles: novel binary contrast agent for high-resolution in vivo X-ray computed tomography angiography. Adv. Healthc. Mater. 2012, 1:461-466.
15. Oh M.H., Lee N., Kim H., Park S.P., Piao Y., Lee J., et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J. Am. Chem. Soc. 2011, 133:5508-5515.
16. Liu Y., Ai K., Liu J., Yuan Q., He Y., Lu L. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray Computed tomography imaging. Angew. Chem. Int. Ed. 2012, 51:1437-1442.
17. Rabin O., Manuel Perez J., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat. Mater. 2006, 5:118-122.
18. Al Zaki A., Joh D., Cheng Z., De Barros A.L.B., Kao G., Dorsey J., Tsourkas A. Gold-loaded polymeric micelles for computed tomography-guided radiation therapy treatment and radiosensitization. Acs Nano 2014, 8:104-112.
19. Popovtzer R., Agrawal A., Kotov N.A., Popovtzer A., Balter J., Carey T.E., et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett. 2008, 8:4593-4596.
20. Xing H., Zheng X., Ren Q., Bu W., Ge W., Xiao Q., et al. Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements. Sci. Rep. 2013, 3. 1751(1)-1751(9).
21. 3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 2012, 33:5384-5393.
22. Xiao Q., Bu W., Ren Q., Zhang S., Xing H., Chen F., et al. Radiopaque fluorescence-transparent TaOx decorated upconversion nanophosphors for in Vivo CT/MR/UCL trimodal imaging. Biomaterials 2012, 33:7530-7539.
23. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for in vivo dual-modality imaging. Adv. Funct. Mater 2011, 21:4470-4477.
24. Xing H., Bu W., Zhang S., Zheng X., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
25. 4:Yb,Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012, 33:4618-4627.
26. Hainfeld J.F., O'Connor M.J., Dilmanian F.A., Slatkin D.N., Adams D.J., Smilowitz H.M. Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Br. J. Radiol. 2011, 84:526-533.
27. Kinsella J.M., Jimenez R.E., Karmali P.P., Rush A.M., Kotamraju V.R., Gianneschi N.C., et al. X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew. Chem. Int. Ed. 2011, 50:12308-12311.
28. 3+-doped upconversion nanoparticles for high-performance T2-weighted brain tumor diagnosis and MR/UCL/CT multimodal imaging. Adv. Funct. Mater 2014, 24:6613-6620.
29. Yu S.B., Watson A.D. Metal-based X-ray contrast media. Chem. Rev. 1999, 99:2353-2377.
30. Yang Y.M., Li C.C., Yin L.K., Feng X. Normalization of T2 relaxation time and apparent diffusion coefficient in relation to the inflammatory changes in the substantia nigra of rats with focal cerebral ischemia. Acta radiol. 2015, 56:837-843.
31. Wang X., Zhuang J., Peng Q., Li Y. A general strategy for nanocrystal synthesis. Nature 2005, 437:121-124.
32. Li L.L., Zhang R., Yin L., Zheng K., Qin W., Selvin P.R., et al. Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes. Angew. Chem. Int. Ed. 2012, 51:6121-6125.
33. Galvez M., York G.E., Eastwood J.D. CT perfusion parameter values in regions of diffusion abnormalities. Am. J. Neuroradiol. 2004, 25:1205-1210.
34. König M. Brain perfusion CT in acute stroke: current status. Eur. J. Radiol. 2003, 45:S11-S22.